日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy

绝经前妇女输卵管中叶酸受体α (FOLR1) 蛋白表达降低:对米尔维妥昔单抗-索拉坦辛治疗中FOLR1 CDx检测的意义

Nasdala, Annika; Kandt, Leonie D; Radner, Martin; Schaumann, Nora; Gronewold, Malte; Hillmann, Pia; Christgen, Henriette; Hachenberg, Jens; Kuehnle, Elna; Hartmann, Christian; Christgen, Matthias

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

完善辅助性 CDK4/6 抑制剂的风险评估,超越临床试验纳入标准:根据 ADAPT 整合复发评分和内分泌反应性

Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

在WSG-ADAPT-TN试验中,免疫调节基因网络可预测三阴性乳腺癌患者对降阶梯、不含蒽环类药物的新辅助化疗的治疗反应和生存期。

Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; Zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J; Trau, Matt; Graeser, Monika; Harbeck, Nadia

A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders

预测性内分泌抵抗指数能够准确区分管腔型乳腺癌治疗的有效者和无效者。

Zhang, Guokun; Jurinovic, Vindi; Bartels, Stephan; Christgen, Matthias; Christgen, Henriette; Kandt, Leonie Donata; Mishieva, Lidiya; Ni, Hua; Raap, Mieke; Klein, Janin; Katzke, Anna-Lena; Hofmann, Winfried; Steinemann, Doris; Kates, Ronald E; Gluz, Oleg; Graeser, Monika; Kümmel, Sherko; Nitz, Ulrike; Plass, Christoph; Lehmann, Ulrich; Zu Eulenburg, Christine; Mansmann, Ulrich; Gerhäuser, Clarissa; Harbeck, Nadia; Kreipe, Hans H

Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者的基因改变、治疗反应和生存率:一项随机临床试验的二次分析

Richters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E; Grischke, Eva-Maria; Altmüller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K; Hahnen, Eric; Harbeck, Nadia

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

利用常规免疫组化标志物预测HER2阴性乳腺癌患者新辅助化疗后的病理完全缓解

Häberle, Lothar; Erber, Ramona; Gass, Paul; Hein, Alexander; Niklos, Melitta; Volz, Bernhard; Hack, Carolin C; Schulz-Wendtland, Rüdiger; Huebner, Hanna; Goossens, Chloë; Christgen, Matthias; Dörk, Thilo; Park-Simon, Tjoung-Won; Schneeweiss, Andreas; Untch, Michael; Nekljudova, Valentina; Loibl, Sibylle; Hartmann, Arndt; Beckmann, Matthias W; Fasching, Peter A

HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

HER2低表达状态作为一种独特的乳腺癌亚型:是谬论还是事实?对WSG试验WSG-ADAPT-HR+/HER2-、WSG-PlanB和WSG-ADAPT-TN的分析

Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kümmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jóźwiak, Katarzyna; Burmeister, Sandy; Zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia

Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast

乳腺浸润性小叶癌形态变异组织学诊断中的陷阱

Floris, Giuseppe; Djerroudi, Lounes; Zels, Gitte; De Schepper, Maxim; Richard, François; Brahimaj, Rigleta; Derksen, Patrick W B; Christgen, Matthias; Lakhani, Sunil R; Van Diest, Paul J; Brogi, Edi; Desmedt, Christine; Schnitt, Stuart J; Vincent-Salomon, Anne

Afadin loss induces breast cancer metastasis through destabilisation of E-cadherin to F-actin linkage.

Afadin 的缺失通过破坏 E-钙黏蛋白与 F-肌动蛋白的连接而诱发乳腺癌转移

Rätze Max Ak, Enserink Lotte Nfl, Ishiyama Noboru, van Kempen Sven, Veltman Christina Hj, Nijman Isaac J, Haakma Wisse E, Caldas Carlos, Bernards René, van Diest Paul J, Christgen Matthias, Koorman Thijs, Derksen Patrick Wb

The Janus Face of SPAG6: Inducing EMT in Luminal Breast Cancer Cells Amidst Widespread Expression Loss in Breast Tumours

SPAG6的双重作用:在乳腺肿瘤中广泛表达缺失的情况下,诱导管腔型乳腺癌细胞发生EMT

Sechi, Antonio; Mijnes, Jolein; Villwock, Sophia; Rose, Michael; Steib, Florian; Bringezu, Sarah; Berger, Jonas; Schalla, Carmen; von Serenyi, Sonja; Dietrich, Jana; Ortiz-Brüchle, Nadina; Heij, Lara; Bednarsch, Jan; Gluz, Oleg; Nitz, Ulrike; Harbeck, Nadia; Graeser, Monika; Zu Eulenburg, Christine; Mohammadian, Mohammad Parsa; Jóźwiak, Katarzyna; Kreipe, Hans-Heinrich; Christgen, Matthias; Radner, Martin; Jonigk, Danny; Dahl, Edgar